Teva Pharmaceutical Industries (TEVA) Return on Capital Employed (2016 - 2025)
Historic Return on Capital Employed for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to 0.08%.
- Teva Pharmaceutical Industries' Return on Capital Employed rose 900.0% to 0.08% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.08%, marking a year-over-year increase of 900.0%. This contributed to the annual value of 0.08% for FY2025, which is 900.0% up from last year.
- Per Teva Pharmaceutical Industries' latest filing, its Return on Capital Employed stood at 0.08% for Q4 2025, which was up 900.0% from 0.06% recorded in Q3 2025.
- Teva Pharmaceutical Industries' Return on Capital Employed's 5-year high stood at 0.08% during Q4 2025, with a 5-year trough of 0.09% in Q1 2021.
- Moreover, its 5-year median value for Return on Capital Employed was 0.01% (2023), whereas its average is 0.0%.
- As far as peak fluctuations go, Teva Pharmaceutical Industries' Return on Capital Employed soared by 1500bps in 2021, and later crashed by -1100bps in 2022.
- Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Return on Capital Employed stood at 0.05% in 2021, then plummeted by -244bps to 0.07% in 2022, then skyrocketed by 121bps to 0.01% in 2023, then tumbled by -177bps to 0.01% in 2024, then skyrocketed by 835bps to 0.08% in 2025.
- Its Return on Capital Employed was 0.08% in Q4 2025, compared to 0.06% in Q3 2025 and 0.03% in Q2 2025.